spacer
spacer

PDBsum entry 1mqy

Go to PDB code: 
protein links
Antibiotic PDB id
1mqy

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
20 a.a.
PDB id:
1mqy
Name: Antibiotic
Title: Nmr solution structure of type-b lantibiotics mersacidin in dpc micelles
Structure: Lantibiotic mersacidin. Chain: a. Synonym: type-b lantibiotics mersacidin
Source: Bacillus sp. Hil-y85/54728. Organism_taxid: 69002. Strain: hil y-85, 54728
NMR struc: 13 models
Authors: S.-T.Hsu,E.Breukink,G.Bierbaum,H.-G.Sahl,B.De Kruijff,R.Kaptein, N.A.Van Nuland,A.M.Bonvin
Key ref:
S.T.Hsu et al. (2003). NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity. J Biol Chem, 278, 13110-13117. PubMed id: 12562773 DOI: 10.1074/jbc.M211144200
Date:
17-Sep-02     Release date:   11-Mar-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P43683  (MRSA_BACSY) -  Lantibiotic mersacidin from Bacillus sp. (strain HIL-Y85/54728)
Seq:
Struc:
68 a.a.
20 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 6 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1074/jbc.M211144200 J Biol Chem 278:13110-13117 (2003)
PubMed id: 12562773  
 
 
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
S.T.Hsu, E.Breukink, G.Bierbaum, H.G.Sahl, B.de Kruijff, R.Kaptein, N.A.van Nuland, A.M.Bonvin.
 
  ABSTRACT  
 
Mersacidin belongs to the type B lantibiotics (lanthionine-containing antibiotics) that contain post-translationally modified amino acids and cyclic ring structures. It targets the cell wall precursor lipid II and thereby inhibits cell wall synthesis. In light of the emerging antibiotics resistance problem, the understanding of the antibacterial activity on a structural basis provides a key to circumvent this issue. Here we present solution NMR studies of mersacidin-lipid II interaction in dodecylphosphocholine (DPC) micelles. Distinct solution structures of mersacidin were determined in three different states: in water/methanol solution and in DPC micelles with and without lipid II. The structures in various sample conditions reveal remarkable conformational changes in which the junction between Ala-12 and Abu-13 (where Abu is aminobutyric acid) effectively serves as the hinge for the opening and closure of the ring structures. The DPC micelle-bound form resembles the previously determined NMR and x-ray crystal structures of mersacidin in pure methanol but substantially deviates from the other two states in our current report. The structural changes delineate the large chemical shift perturbations observed during the course of a two-step (15)N-(1)H heteronuclear single quantum coherence titration. They also modulate the surface charge distribution of mersacidin suggesting that electrostatics play a central role in the mersacidin-lipid II interaction. The observed conformational adaptability of mersacidin might be a general feature of lipid II-interacting antibiotics/peptides.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Primary structures of mersacidin (A) and lipid II (B). A, post-translationally modified amino acids are highlighted in gray, and their chemical structures are depicted below. B, GlcNAc, N-acetylglucosamine; MurNAc, N-acetylmuramic acid.
Figure 8.
Fig. 8. A, representative structures (closest to average) of each structure ensemble. The Glu-17 side chain is shown in red. The hinge residue Abu-13 is shown in green. The structures were fitted on backbone heavy atoms of residues 13-20 (colored blue). The remainder of the structure is shown in gray. B, surface electrostatic potential of mersacidin in different sample conditions calculated with MOLMOL (40). Positive and negative potentials are colored blue and red, respectively. The structures are in the same orientation as in A. C, 90° rotation along the x axis of the above structures. The charge distributions reveal the increase of charge accessibility after the addition of lipid II in the hydrophobic DPC micelle solution. The structure of mersacidin in DPC micelles resembles the x-ray structure that was solved in pure methanol.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2003, 278, 13110-13117) copyright 2003.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21276942 T.Caetano, J.M.Krawczyk, E.Mösker, R.D.Süssmuth, and S.Mendo (2011).
Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.
  Chem Biol, 18, 90.  
20382768 K.Okuda, S.Yanagihara, T.Sugayama, T.Zendo, J.Nakayama, and K.Sonomoto (2010).
Functional significance of the E loop, a novel motif conserved in the lantibiotic immunity ATP-binding cassette transport systems.
  J Bacteriol, 192, 2801-2808.  
21035738 S.Suda, A.Westerbeek, P.M.O'Connor, R.P.Ross, C.Hill, and P.D.Cotter (2010).
Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.
  Chem Biol, 17, 1151-1160.  
19666597 J.B.Hamburger, A.J.Hoertz, A.Lee, R.J.Senturia, D.G.McCafferty, and P.J.Loll (2009).
A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface.
  Proc Natl Acad Sci U S A, 106, 13759-13764.  
19429551 T.Böttiger, T.Schneider, B.Martínez, H.G.Sahl, and I.Wiedemann (2009).
Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.
  Appl Environ Microbiol, 75, 4427-4434.  
19689109 Z.A.Waller, S.A.Sewitz, S.T.Hsu, and S.Balasubramanian (2009).
A small molecule that disrupts G-quadruplex DNA structure and enhances gene expression.
  J Am Chem Soc, 131, 12628-12633.  
18215770 F.Castiglione, A.Lazzarini, L.Carrano, E.Corti, I.Ciciliato, L.Gastaldo, P.Candiani, D.Losi, F.Marinelli, E.Selva, and F.Parenti (2008).
Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.
  Chem Biol, 15, 22-31.  
18940665 L.E.Cooper, A.L.McClerren, A.Chary, and W.A.van der Donk (2008).
Structure-activity relationship studies of the two-component lantibiotic haloduracin.
  Chem Biol, 15, 1035-1045.  
17096664 A.Dufour, T.Hindré, D.Haras, and J.P.Le Pennec (2007).
The biology of lantibiotics from the lacticin 481 group is coming of age.
  FEMS Microbiol Rev, 31, 134-167.  
17603894 A.L.Lomize, I.D.Pogozheva, M.A.Lomize, and H.I.Mosberg (2007).
The role of hydrophobic interactions in positioning of peripheral proteins in membranes.
  BMC Struct Biol, 7, 44.  
17407564 E.B.O'Connor, P.D.Cotter, P.O'Connor, O.O'Sullivan, J.R.Tagg, R.P.Ross, and C.Hill (2007).
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.
  BMC Microbiol, 7, 24.  
17506681 J.M.Willey, and W.A.van der Donk (2007).
Lantibiotics: peptides of diverse structure and function.
  Annu Rev Microbiol, 61, 477-501.  
17927474 N.I.Martin, and E.Breukink (2007).
Expanding role of lipid II as a target for lantibiotics.
  Future Microbiol, 2, 513-525.  
  19079554 R.S.Narayan, and M.S.Vannieuwenhze (2007).
Synthesis of Substrates and Biochemical Probes for Study of the Peptidoglycan Biosynthetic Pathway.
  European J Org Chem, 2007, 1399-1414.  
17085596 A.L.McClerren, L.E.Cooper, C.Quan, P.M.Thomas, N.L.Kelleher, and W.A.van der Donk (2006).
Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.
  Proc Natl Acad Sci U S A, 103, 17243-17248.  
16531990 E.Breukink, and B.de Kruijff (2006).
Lipid II as a target for antibiotics.
  Nat Rev Drug Discov, 5, 321-332.  
16957199 I.Holtsmark, D.Mantzilas, V.G.Eijsink, and M.B.Brurberg (2006).
Purification, characterization, and gene sequence of michiganin A, an actagardine-like lantibiotic produced by the tomato pathogen Clavibacter michiganensis subsp. michiganensis.
  Appl Environ Microbiol, 72, 5814-5821.  
16771847 I.Wiedemann, T.Böttiger, R.R.Bonelli, A.Wiese, S.O.Hagge, T.Gutsmann, U.Seydel, L.Deegan, C.Hill, P.Ross, and H.G.Sahl (2006).
The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
  Mol Microbiol, 61, 285-296.  
16597986 I.Wiedemann, T.Böttiger, R.R.Bonelli, T.Schneider, H.G.Sahl, and B.Martínez (2006).
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
  Appl Environ Microbiol, 72, 2809-2814.  
17046525 J.Nagao, S.M.Asaduzzaman, Y.Aso, K.Okuda, J.Nakayama, and K.Sonomoto (2006).
Lantibiotics: insight and foresight for new paradigm.
  J Biosci Bioeng, 102, 139-149.  
16323221 J.S.Grinstead, S.T.Hsu, W.Laan, A.M.Bonvin, K.J.Hellingwerf, R.Boelens, and R.Kaptein (2006).
The solution structure of the AppA BLUF domain: insight into the mechanism of light-induced signaling.
  Chembiochem, 7, 187-193.
PDB code: 2bun
17076667 P.D.Cotter, L.H.Deegan, E.M.Lawton, L.A.Draper, P.M.O'Connor, C.Hill, and R.P.Ross (2006).
Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
  Mol Microbiol, 62, 735-747.  
16957223 S.M.Asaduzzaman, J.Nagao, Y.Aso, J.Nakayama, and K.Sonomoto (2006).
Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1.
  Appl Environ Microbiol, 72, 6012-6017.  
16118063 G.C.Patton, and W.A.van der Donk (2005).
New developments in lantibiotic biosynthesis and mode of action.
  Curr Opin Microbiol, 8, 543-551.  
15702316 H.He (2005).
Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria.
  Appl Microbiol Biotechnol, 67, 444-452.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer